UPDATE 2-U.S. FDA approves Amgen's copy of AbbVie arthritis drug Humira
September 23, 2016 at 17:50 PM EDT
WASHINGTON, Sept 23 (Reuters) - The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar version of AbbVie's top-selling arthritis drug, Humira.
